Insights
In-depth regulation interpretation, authoritative policy insights shared by our experts and specialists.
Hot topic
REPORT
Post-approval Changes to Active Pharmaceutical Ingredients (APIs), Excipients, and Packaging Materials (AEPs) in China
Dec 13, 2023
REPORT
[Updated] China Pharma Guidelines: Nonclinical Study, Clinical Trial, Marketing Authorization and More
Oct 17, 2023